FDA.reportPublic FDA data

3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [Novolin]

RxCUI
2049380
RxNorm name
3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [Novolin]
Display name
3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [Novolin]
Full name
3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [Novolin]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
019991Novolin 70/30insulin isophane human and insulin human351(a)OTC2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Novolin 70/30HUMAN INSULINNovo Nordisk508a2763-3cb7-4be5-9e53-544e84cd9b1f2022-11-23Warnings, Adverse reactionsExact identifier
rxcui: 2049380

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
508a2763-3cb7-4be5-9e53-544e84cd9b1fNovoLIN 70/30 in 3 ML Pen Injector [PSN] · 3 ML insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Pen Injector [Novolin] [SBD] · Novolin 70/30 per 3 ML Pen Injector [SY]318These highlights do not include all the information needed to use NOVOLIN 70/30 safely and effectively. See full prescribing information for NOVOLIN 70/30. NOVOLIN ® 70/30 (insulin isophane human and insulin human) injectable suspension, for subcutaneous use Initial U.S. Approval: 199120221123